CUREGHEM PNEUS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CUREGHEM PNEUS
Largest movements
- Tangible fixed assets -€3,668
down €3,668 (-42.1%), from €8,719 to €5,051
- Stocks and contracts +€806
up €806 (+53.7%), from €1,500 to €2,306
- Receivables within one year +€182
new in 2025: €182
- Contributions +€15,000
new in 2025: €15,000
- Profit (loss) carried forward -€9,436
down €9,436, from €1,471 to -€7,964
- Other debts -€3,525
down €3,525 (-82.8%), from €4,255 to €730
- Trade debts -€2,739
down €2,739 (-95.9%), from €2,855 to €116
- Tax, wage and social debts -€1,965
down €1,965 (-94.9%), from €2,070 to €105
- Gross operating margin -€13,959
down €13,959, from €13,046 to -€913
- Depreciation -€3,103
down €3,103 (-30.8%), from €10,061 to €6,958
- Financial charges +€427
up €427 (+56.3%), from €759 to €1,186
- Taxes -€368
no longer reported in 2025 (was €368)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,651 | €7,987 | -€2,665 | -25.0% |
| Fixed assets | 21/28 | €8,719 | €5,051 | -€3,668 | -42.1% |
| Tangible fixed assets | 22/27 | €8,719 | €5,051 | -€3,668 | -42.1% |
| Plant, machinery and equipment | 23 | €8,719 | €5,051 | -€3,668 | -42.1% |
| Current assets | 29/58 | €1,933 | €2,936 | +€1,003 | +51.9% |
| Stocks and contracts in progress | 3 | €1,500 | €2,306 | +€806 | +53.7% |
| Stocks | 30/36 | €1,500 | €2,306 | +€806 | +53.7% |
| Amounts receivable within one year | 40/41 | - | €182 | +€182 | |
| Trade receivables | 40 | - | €182 | +€182 | |
| Cash at bank and in hand | 54/58 | €5 | €8 | +€3 | +68.7% |
| Deferred charges and accrued income | 490/1 | €428 | €440 | +€13 | +3.0% |
| Total equity and liabilities | 10/49 | €10,651 | €7,987 | -€2,665 | -25.0% |
| Equity | 10/15 | €1,471 | €7,036 | +€5,564 | +378% |
| Contributions | 10/11 | - | €15,000 | +€15,000 | |
| Profit (loss) carried forward | 14 | €1,471 | -€7,964 | -€9,436 | |
| Amounts payable | 17/49 | €9,180 | €951 | -€8,229 | -89.6% |
| Amounts payable within one year | 42/48 | €9,180 | €951 | -€8,229 | -89.6% |
| Trade debts | 44 | €2,855 | €116 | -€2,739 | -95.9% |
| Suppliers | 440/4 | €2,855 | €116 | -€2,739 | -95.9% |
| Taxes, remuneration and social security | 45 | €2,070 | €105 | -€1,965 | -94.9% |
| Taxes | 450/3 | €2,070 | €105 | -€1,965 | -94.9% |
| Other amounts payable | 47/48 | €4,255 | €730 | -€3,525 | -82.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €10,061 | €6,958 | -€3,103 | -30.8% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | €13,046 | -€913 | -€13,959 | |
| Operating profit (loss) | 9901 | €2,598 | -€8,271 | -€10,868 | |
| Financial income | 75/76B | €0 | €22 | +€21 | +26,838% |
| Recurring financial income | 75 | €0 | €22 | +€21 | +26,838% |
| Financial charges | 65/66B | €759 | €1,186 | +€427 | +56.3% |
| Recurring financial charges | 65 | €759 | €1,186 | +€427 | +56.3% |
| Profit (loss) for the period before taxes | 9903 | €1,839 | -€9,436 | -€11,274 | |
| Income taxes | 67/77 | €368 | - | -€368 | |
| Profit (loss) for the period | 9904 | €1,471 | -€9,436 | -€10,907 | |
| Profit (loss) for the period to be appropriated | 9905 | €1,471 | -€9,436 | -€10,907 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.